173 related articles for article (PubMed ID: 38200153)
21. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia.
Yaktapour N; Übelhart R; Schüler J; Aumann K; Dierks C; Burger M; Pfeifer D; Jumaa H; Veelken H; Brummer T; Zirlik K
Blood; 2013 Aug; 122(9):1621-33. PubMed ID: 23863897
[TBL] [Abstract][Full Text] [Related]
23. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
24. Development of the phenylpyrazolo[3,4-
Lee HJ; Pham PC; Pei H; Lim B; Hyun SY; Baek B; Kim B; Kim Y; Kim MH; Kang NW; Min HY; Kim DD; Lee J; Lee HY
Theranostics; 2021; 11(4):1918-1936. PubMed ID: 33408789
[No Abstract] [Full Text] [Related]
25. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
Zhao Z; Zhang N; Li A; Zhou B; Chen Y; Chen S; Huang M; Wu F; Zhang L
Cancer Lett; 2020 Aug; 485():14-26. PubMed ID: 32417396
[TBL] [Abstract][Full Text] [Related]
26. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
27. IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas.
Huang X; Park H; Greene J; Pao J; Mulvey E; Zhou SX; Albert CM; Moy F; Sachdev D; Yee D; Rader C; Hamby CV; Loeb DM; Cairo MS; Zhou X
PLoS One; 2015; 10(7):e0133152. PubMed ID: 26173023
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells.
Lee Y; Wang Y; James M; Jeong JH; You M
Mol Carcinog; 2016 May; 55(5):991-1001. PubMed ID: 26052929
[TBL] [Abstract][Full Text] [Related]
29. Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.
Guerard M; Robin T; Perron P; Hatat AS; David-Boudet L; Vanwonterghem L; Busser B; Coll JL; Lantuejoul S; Eymin B; Hurbin A; Gazzeri S
Cancer Lett; 2018 Apr; 420():146-155. PubMed ID: 29421153
[TBL] [Abstract][Full Text] [Related]
30. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.
Hua J; Wang X; Ma L; Li J; Cao G; Zhang S; Lin W
Mol Cancer; 2022 Jun; 21(1):123. PubMed ID: 35668527
[TBL] [Abstract][Full Text] [Related]
31. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
32. Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface.
Lee WH; Seo D; Lim SG; Suk K
Front Immunol; 2019; 10():262. PubMed ID: 30838001
[TBL] [Abstract][Full Text] [Related]
33. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.
Kang Z; Yu Y; Zhu YJ; Davis S; Walker R; Meltzer PS; Helman LJ; Cao L
Oncogene; 2014 Dec; 33(50):5697-705. PubMed ID: 24292683
[TBL] [Abstract][Full Text] [Related]
35. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor.
Yuan Y; Shen Y; Xue L; Fan H
PLoS One; 2013; 8(9):e73604. PubMed ID: 24039995
[TBL] [Abstract][Full Text] [Related]
36. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.
Png KJ; Halberg N; Yoshida M; Tavazoie SF
Nature; 2011 Dec; 481(7380):190-4. PubMed ID: 22170610
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells.
Dong A; Kong M; Ma Z; Qian J; Cheng H; Xu X
Acta Biochim Biophys Sin (Shanghai); 2008 Jun; 40(6):497-504. PubMed ID: 18535748
[TBL] [Abstract][Full Text] [Related]
38. Glucosidase II beta subunit (GluIIβ) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner.
Khaodee W; Inboot N; Udomsom S; Kumsaiyai W; Cressey R
Cell Oncol (Dordr); 2017 Dec; 40(6):579-591. PubMed ID: 28929344
[TBL] [Abstract][Full Text] [Related]
39. A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.
Sachdev D; Hartell JS; Lee AV; Zhang X; Yee D
J Biol Chem; 2004 Feb; 279(6):5017-24. PubMed ID: 14615489
[TBL] [Abstract][Full Text] [Related]
40. Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas.
Pelekanou V; Notas G; Theodoropoulou K; Kampa M; Takos D; Alexaki VI; Radojicic J; Sofras F; Tsapis A; Stathopoulos EN; Castanas E
Anal Cell Pathol (Amst); 2011; 34(1-2):49-60. PubMed ID: 21483105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
